Jill Leversage - 13 Dec 2021 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role: Director
Signature: /s/ Jill Leversage
Issuer symbol: AUPH
Transactions as of: 13 Dec 2021
Net transactions value: +$32,064
Form type: 4
Filing time: 15 Dec 2021, 15:09:55 UTC
Previous filing: 16 Jun 2021
Next filing: 20 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUPH	Common Stock	Purchase	$32,064	+1,600	+43%	$20.04	5,300	13 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $20.02 to $20.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Content

The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $20.02 to $20.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.